The B-cell Receptor Blueprint in Lymphoma: Mechanisms and Therapeutic Opportunities
Open Access
- 2 March 2026
- journal article
- Published by American Association for Cancer Research (AACR) in Blood Cancer Discovery
- Vol. 7 (3) , 380-393
Abstract
The B-cell receptor (BCR) is central to normal and malignant B-cell biology, integrating intrinsic programs with microenvironmental cues to shape cell fate. Across mature B-cell lymphomas, differences in BCR expression, class, and signaling mode define distinct pathogenetic routes and therapeutic vulnerabilities, ranging from BCR-dependent to BCR-silent states. We propose a BCR blueprint that positions these tumors along a continuum of signaling modes and class-imposed functions, emphasizing germinal center–derived lymphomas. This framework links specific BCR states to genetic lesions and microenvironmental niches, underscoring the value of routinely monitoring BCR features to track tumor evolution and inform therapy. Significance: B-cell lymphomas exploit diverse BCR expression levels, classes, and signaling modes that span BCR-addicted to BCR-silent states and shape their genetic programs and therapeutic dependencies. A unified BCR blueprint reframes these diseases along a continuum of BCR signaling and isotype-driven biology, particularly in germinal center–derived entities. Embedding this blueprint into routine clinical testing has the potential to improve prediction of response or resistance to BCR-targeted and other mechanism–based therapies.Keywords
All Related Versions
This publication has 127 references indexed in Scilit:
- Goodbye flat lymphoma biologyFEBS Letters, 2025
- Lymphoma‐associated mutations in autoreactive memory B cells of patients with Sjögren's syndromeThe Journal of Pathology, 2023
- Bruton Tyrosine Kinase Inhibitors in B-Cell Malignancies: Their Use and Differential FeaturesTargeted Oncology, 2021
- The resistance mechanisms and treatment strategies of BTK inhibitors in B‐cell lymphomaHematological Oncology, 2021
- Ontogeny of human B1 cellsInternational Journal of Hematology, 2019
- Genetic and phenotypic analysis of B‐cell post‐transplant lymphoproliferative disorders provides insights into disease biologyHematological Oncology, 2008
- Analysis of immunoglobulin heavy and light chain variable genes in post‐transplant lymphoproliferative disordersHematological Oncology, 2006
- IGH switch breakpoints in Burkitt lymphoma: Exclusive involvement of noncanonical class switch recombinationGenes, Chromosomes and Cancer, 2006
- Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphomaInternational Journal of Cancer, 2005
- Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections.The EMBO Journal, 1993